How about the Indian version of Carfilzomib?

Carfilzomib (Carfilzomib) currently has no officially launched generic version in India. Carfilzomib is an important drug used to treat multiple myeloma (Multiple Myeloma), a malignant bone marrow cancer. Carfilzomib belongs to the proteasome inhibitor (Proteasome Inhibitors) drug class and is a very effective treatment drug, especially suitable for patients with relapsed or refractory multiple myeloma. Carfilzomib. Carfilzomib is already on the market in China and is included in medical insurance. Patients can buy it domestically at a price of around 8,000 to 9,000 yuan. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000.